Catalyst Pharmaceuticals Announces Financial Report Schedule
In a significant announcement, Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX), a biopharmaceutical company engaged in developing treatments for rare diseases, has disclosed the date for its third quarter 2024 financial results. The results will be released following the closure of the market on a specified Wednesday in early November.
Conference Call and Webcast Details
On Thursday, the day after the financial results announcement, Catalyst's management will host a conference call and webcast at 8:30 AM ET. This event aims to provide insight into the financial performance and strategic direction of the company.
How to Join the Conference Call
Investors and interested parties can participate by dialing the US/Canada toll-free number or the international dial-in number provided. These numbers ensure that everyone can join regardless of their geographical location.
Webcast Availability
The webcast will be available under the Investor Relations section of Catalyst's website. Following the live event, a replay will remain accessible for at least 30 days, allowing those who couldn't attend live to catch up.
Understanding Catalyst Pharmaceuticals
Catalyst Pharmaceuticals is dedicated to addressing the needs of patients with rare and hard-to-treat diseases. Focusing on developing and commercializing novel therapies, the company prides itself on its patient-centric approach. This commitment is evidenced by robust support services designed to facilitate patient access to their medications.
Strategic Growth and Innovation
The biopharmaceutical company has a proven history of bringing essential treatments to the market. Currently based in Coral Gables, Catalyst is not only well-established in the U.S. but is also actively exploring global partnerships to expand its reach. Their aim is to make innovative therapies available to patients around the world.
Recent Recognitions
Recently, Catalyst achieved recognition from Forbes on its prestigious list of America’s most successful small-cap companies. This accolade highlights the company’s growth trajectory and its influence within the biopharmaceutical sector.
Contact Information for Investors and Media
For further inquiries, Catalyst Pharmaceuticals provides contact information for both investor relations and media. This facilitates better communication and dissemination of information pertaining to advancements, research, and overall company status.
Frequently Asked Questions
When will Catalyst Pharmaceuticals release their Q3 2024 results?
Catalyst Pharmaceuticals is scheduled to announce its third quarter 2024 financial results after the market closes on a specified Wednesday in early November.
How can I join the conference call?
Individuals can join the conference call by dialing the U.S./Canada toll-free number or the international number provided in the announcement.
Where can I access the webcast of the conference call?
The webcast will be available on the Investor Relations section of Catalyst’s website, with a replay accessible for at least 30 days following the live event.
What is the focus of Catalyst Pharmaceuticals?
Catalyst Pharmaceuticals specializes in developing and commercializing innovative treatments for rare diseases, significantly improving patient care.
How did Catalyst Pharmaceuticals gain recognition recently?
The company was recognized by Forbes as one of America’s most successful small-cap companies, reflecting its impactful growth within the industry.
